EMD Serono to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021
Retrieved on:
Sunday, September 12, 2021
Managed Care, Research, Radiology, Pharmaceutical, Oncology, Hospitals, Clinical Trials, Science, Biotechnology, Nursing, FDA, Health, Other Science, BAVENCIO® (avelumab), Tepotinib, Berzosertib, Bintrafusp Alfa, EMD Serono, Inc., Merck KGaA, Darmstadt, Germany, BAVENCIO® (AVELUMAB), TEPOTINIB, BERZOSERTIB, BINTRAFUSP ALFA, EMD SERONO, INC., MERCK KGAA, DARMSTADT, GERMANY
EMD Serono is a science-led organization dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer.
Key Points:
- EMD Serono is a science-led organization dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer.
- Upon improvement to Grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month.
- Consider administration of other systemic immunosuppressants in patients whose immune-mediated adverse reactions are not controlled with corticosteroid therapy.
- The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.